These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
232 related items for PubMed ID: 7518114
1. Possibility of prevention of hyperacute rejection by DAF and CD59 in xenotransplantation. Miyagawa S, Shirakura R, Matsumiya G, Nakata S, Matsuda H, Hatanaka M, Matsumoto M, Seya T. Transplant Proc; 1994 Jun; 26(3):1235-8. PubMed ID: 7518114 [No Abstract] [Full Text] [Related]
2. In vitro and in vivo studies to prevent hyperacute rejection. Miyagawa S, Mikata M, Matsuda H, Ikawa M, Okabe M, Nagasawa S, Matsumoto M, Seya T, Shirakura R. Transplant Proc; 1996 Apr; 28(2):1031-3. PubMed ID: 8623217 [No Abstract] [Full Text] [Related]
3. Studies on transfer of primate membrane-associated complement inhibitors from recipient blood to porcine donor organs. Kroshus TJ, Bolman RM, Dalmasso AP. Transplant Proc; 1996 Apr; 28(2):601-2. PubMed ID: 8623295 [No Abstract] [Full Text] [Related]
5. Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion. McCurry KR, Kooyman DL, Diamond LE, Byrne GW, Logan JS, Platt JL. Transplantation; 1995 Apr 27; 59(8):1177-82. PubMed ID: 7537395 [Abstract] [Full Text] [Related]
6. Development and analysis of transgenic pigs expressing the human complement regulatory protein CD59 and DAF. Byrne G, McCurry K, Martin M, Platt J, Logan J. Transplant Proc; 1996 Apr 27; 28(2):759. PubMed ID: 8623385 [No Abstract] [Full Text] [Related]
13. Cytoprotective effect of CD59 antigen on xenotransplantation immunity. Akami T, Sawada R, Minato N, Naruto M, Yamada A, Imanishi J, Mitsuo M, Nakai I, Okamoto M, Nakajima H. Transplant Proc; 1992 Apr 27; 24(2):485-7. PubMed ID: 1373542 [No Abstract] [Full Text] [Related]
15. Genetic engineering of the donor species to control hyperacute xenograft rejection. White DJ, Cozzi E, Langford G, Oglesby T, Wang MW, Wright L, Wallwork J. Adv Nephrol Necker Hosp; 1995 Apr 27; 24():331-40. PubMed ID: 7572417 [No Abstract] [Full Text] [Related]
16. Effect of transfected MACIF (CD59) on complement-mediated swine endothelial cell lysis, compared with those of membrane cofactor protein (CD46) and decay-accelerating factor (CD55). Miyagawa S, Shirakura R, Nakata S, Izutani H, Matsuda H, Iwata K, Nagasawa S, Terado A, Hatanaka M, Matsumoto M. Transplant Proc; 1995 Feb 27; 27(1):328-9. PubMed ID: 7533401 [No Abstract] [Full Text] [Related]
17. Effect of transfectant molecules, MCP, DAF, and MCP/DAF hybrid on xenogeneic vascular endothelium. Miyagawa S, Shirakura R, Izutani H, Matsumiya G, Nakata S, Matsuda H, Iwata K, Nagasawa S, Terado A, Matsumoto M. Transplant Proc; 1994 Jun 27; 26(3):1253-4. PubMed ID: 7518122 [No Abstract] [Full Text] [Related]
18. Adenovirus-mediated gene transfer of triple human complement regulating proteins (DAF, MCP and CD59) in the xenogeneic porcine-to-human transplantation model. Part II: xenogeneic perfusion of the porcine liver in vivo. Shiraishi M, Oshiro T, Nozato E, Nagahama M, Taira K, Nomura H, Sugawa H, Muto Y. Transpl Int; 2002 May 27; 15(5):212-9. PubMed ID: 12012041 [Abstract] [Full Text] [Related]